Calderón SJV, Muñoz REG, Quintanar EMA

Language: Spanish
References: 36
Page: 53-66
PDF size: 372.20 Kb.

ABSTRACT

Many diseases are associated with oxidative stress, diabetes mellitus is no exception. However, there are few diseases that meet the criteria for being oxidative disease. The study the effects of increased glucose concentration in different models has led to propose that oxidative processes are involved in the pathogenesis, progression, complications and poor prognosis of diabetes mellitus. Experimental data are solid and despite the complex and varied reactions that are induced due to the increased glucose concentration various mechanisms of damage that directly or indirectly involve oxidants and participates in antioxidant status has been established. The overproduction of reactive oxygen species produced by increasing the activity of the electron transport chain, the autoxidation of glucose, sorbitol pathway, the glycation of proteins, advanced glycation products, the excessive expense of reduced cofactors; coupled with the reduction of antioxidant defenses, the capacity of the cell redox buffering capacity antioxidant and generates a pro-oxidant conditions oxidative damage to proteins, lipids, nucleic acids and carbohydrates, all of which can contribute in different ways to development of different disease manifestations of diabetic patients. However, despite advances in models and mechanisms of injury, has not yet had enough solid scientific information that antioxidant treatment is integrated with official recommendations of international agencies in the treatment of diabetes mellitus and its complications.

REFERENCES

1. ADA (American Diabetes Association) (2013) Diagnosis and classification of Diabetes Mellitus. Diabetes Care, 36, Supplement1, January. U.S.A. pp. 64-74.

2. IDF Diabetes Atlas, International Diabetes Federation (2012). http://www.diabetesatlas. org

3. ENSANUT. Resultados de la Encuesta Nacional de Salud 2012. Salud Pública México 2012.

4. Golbidi S, Ebadi SA, Laher I (2011) Antioxidants in the treatment of Diabetes. Curr Diabetes Rev 7(2): 106-125.

5. Forbes, JM, Cooper, ME (2013) Mechanisms of diabetic complications. Physiol Rev 93(1): 137-188.

6. Kaul K, Tarr J M, Ahmad SI, Kohner EM, Chibber R (2012) Introduction to diabetes mellitus. Adv Exp Med Biol 771:1-11.

7. Quintanar-Escorza, MA y Calderón-Salinas, JV (2009) La capacidad antioxidante total. Bases y aplicaciones. REB 28(3):89-101.

8. Kaneto H, Katakami N, Matsuhisa M, Matsuoka TA (2010) Role of Reactive Oxygen Species in the Progression of Type 2 Diabetes and Atherosclerosis. Mediators Inflamm 2010: Article ID 453892,1 pages, doi:10.1155/2010/453892.

9. Likidlilid A, Patchanans N, Peerapatdit T, Sriratanasathavorn C. (2010) Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients. J Med Assoc Thai 93(6):682-693.

10. Takayanagi R, Inoguchi T, Ohnaka K (2011) Clinical and experimental evidence for oxidative stress as an exacerbating factor of diabetes mellitus. J Clin Biochem Nutr 48 (1): 72-77.

11. Srivatsan R, Das S, Gadde R, Manoj-Kumar K, Taduri S, Rao N, Ramesh B, Bajarani A, Shah Kaajal, Kamireddy S C, Priyatham G, Kamatha A, Rao A (2009) Antioxidants and lipid peroxidation status in diabetic patients with and without complications. Arch Iran Med 12:(2) 121-127.

12. Lam CS, Benzie IF, Choi SW, Chan LY, Yeung VT, Woo GC (2011) Relationships among diabetic retinopathy, antioxidants, and glycemic control. Optom Vis Sci 88(2): 251-256.

13. Tsutsui H, Kinugawa S, Matsushima S, Yokota, T (2011) Oxidative stress in cardiac and skeletal muscle dysfunction associated with diabetes mellitus. J Clin Biochem Nutr 48(1): 68-71.

14. Singh DK, Winocour P, Farrington K (2011) Oxidative stress in early diabetic nephropathy: fueling the fire. Nat Rev Endocrinol 7(3): 176- 184.

15. Calderón-Salinas JV, Muñoz-Reyes EG, Guerrero-Romero M, Rodríguez-Moran M, Bracho-Riquelme RL, Carrera-Gracia MA, Quintanar-Escorza, MA. (2011) Eryptosis and oxidative damage in type 2 diabetic mellitus patients with chronic kidney disease. J Mol Cell Biochem 357(1-2):171-179.

16. Green K, Brand MD, Murphy MP (2004) Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. Diabetes 53 1:S110-8.

17. Naudi A, Jove M, Ayala V, Cassanye A, Serrano J, Gonzalo H, Boada J, Prat J, Portero-Otin M, Pamplona R (2012) Cellular dysfunction in diabetes as maladaptive response to mitochondrial oxidative stress. Exp Diabetes Res 2012:696215.

18. Yamagishi S (2011) Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes. Exp Gerontol 46(4): 217-224.

19. Thornalley PJ, Langborg A, Minhas HS (1999) Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J. 344 Pt 1:109-116.

20. Das Evcimen N, King GL. (2007) The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol Res 55(6): 498-510.

21. Hashim Z, Zarina S (2012) Osmotic stress i n d u c e d ox i d a t i ve d ama g e : p o s s i b l e mechanism of cataract formation in diabetes. J Diabetes Complication 26(4): 275-279.

22. Goh SY, Cooper ME (2008) Clinical review: The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 93(4):1143-1152.

23. Whiting PH, Kalansooriya A, Holbrook I, Haddad F, Jennings PE (2008) The relationship between chronic glycacemic control and oxidative stress in type 2 diabetes mellitus. Br J Biomed Sci 65(2):71-74.

24. Chevion M, Berenshtein E, Stadtman ER (2002) Human studies related to protein oxidation: Protein carbonyl content as a marker of damage. Free Radical Research. 33 Suppl:S99-108.

25. Beisswenger PJ, Drummond KS, Nelson RG, Howell SK, Szwergold BS, Mauer M (2005) Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress. Diabetes 54(11):3274-5281

26. Miyata T (2002) Alterations of non-enzymatic biochemistry in uremia, diabetes and aterosclerosis (“Carbonyl stress”) Bulletin et memoires d l’Académie Royale de Medecine de Belgique; 157(3-4): 189-196.

27. Pessler D, Rudich A, Bashan N (2001) Oxidative stress impairs nuclear proteins binding to the insulin responsive element in the GLUT 4 promoter. Diabetologia 44(12): 2156-2164.

28. Johansen JS, Harris AK, Rychly DJ, Ergul A (2005) Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc Diabetol 29;4(1):5.

29. Maritim AC, Sanders RA, Watkins JB (2003) Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 17(1):24- 38.

30. Aronson, D, Rayfiel, EJ. (2002) How hyperglycemia promotes aterosclerosis: Molecular mechanisms. Cardiovascular Diabetology 1:1.

31. Giacco F, Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res 107(9):1058-1070.

32. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, Channon KM (2002) Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105(14): 1656-1662.

33. Polidori MC, Praticó D, Savino K, Rokach J, Stahl W, Mecocci P (2004) Increased F2 isoprostane plasma levels in patients with congestive heart failure are correlated with antioxidant status and disease severity. J Card Fail 10(4):334-338.

34. Sheikh-Ali M, Chehade JM, Mooradian AD (2011) The antioxidant paradox in diabetes mellitus. Am J Ther 18(3):266-278.

35. Singh PP, Mahadi F, Roy A, Sharma P (2009) Reactive oxygen species, reactive nitrogen species and antioxidants in etiopathogenesis of diabetes mellitus type-2. Indian J Clin Biochem 24(4):324-342.

36. Tabatabaei-Malazy O, Larijani B, Abdollahi M (2012) A systematic review of in vitro studies conducted on effect of herbal products on secretion of insulin from Langerhans islets. J Pharm Pharm Sci 15(3):447-466.